We have various ongoing studies taking place at the moment, some focusing on causes of Parkinson’s and in particular how genes play a role in the condition. Other research is looking into quality of life for people with Parkinson’s and how this can be improved. All our research teams would welcome your interest and are available to answer questions and hear your views.
Please take a look at some of our current studies below or download 'Current Parkinson's research opportunities'.
Care of Late-Stage Parkinsonism (CLaSP)
This study aims to evaluate the needs and provision of care for patients who have had Parkinsonism for several years and their carers. It covers six European countries, to compare the effectiveness of different health and social care systems and to lay the foundation for improved outcomes across this population. The researchers are interested to talk to people who have had Parkinson’s for longer than seven years and their carers. Find out more.
Parkinson’ Families Project and 100,000 Genomes Project
We are interested in making contact with patients with early onset (age at onset under 45) or familial Parkinson’s (other family members affected). Patients in these groups may be able to enter the Parkinson's Family Project or the 100 000 genomes project, both of which involve donating blood samples for genetic research.
It’s rare for Parkinson’s to be inherited – the condition is directly caused by genetic changes in less than 5% of cases – but of these cases changes in a gene called LRRK2 are the most common cause. LRRK2 has a familial pattern of inheritance and variations in this gene are more common in certain populations including the Ashkenazi Jewish community and people of north African descent. The researchers are interested in talking people with a family history of Parkinson’s and who come from these communities. Find out more.
RAPSODI is a pioneering study which uses the internet to find new ways to diagnose Parkinson's earlier and develop life changing treatments. The research team is interested in the link between the GBA gene, a known factor in a condition called Gaucher disease, and Parkinson’s, and are interested in talking to people with Gaucher disease and their relatives.
VIP Vision in Parkinson’s
VIP Vision in Parkinson’s is a study exploring some of the changes people with Parkinson’s experience with perception in vision.
Best of luck to Andrew Symes competing in the Gauntlet half Iron Triathlon on Sunday in aid of the Chronic Granulom… twitter.com/i/web/status/1…
We are seeking a motivated and enthusiastic individual to be part of the ophthalmic team at Royal Free London NHS F… twitter.com/i/web/status/1…